Results 181 to 190 of about 70,416 (256)

Exploring the Anticancer Potential of Schiff Base Complexes: A Mini‐Review

ChemMedChem, Volume 21, Issue 17, 14 September 2026.
Schiff base metal complexes as promising anticancer agents: highlighting DNA interactions, cytotoxicity, molecular targets, and mechanisms of cancer cell death. Schiff bases are well known for their ability to form stable coordination compounds with several transition metals, making them valuable for medicinal chemistry purposes.
Atif Ahmad, Anam, Marcos V. Palmeira‐Mello, Sabir Khan, José Clayston Melo Pereira   +4 more
wiley   +1 more source

Patient characteristics to guide personalized treatment decisions and prognostication in hepatocellular carcinoma. [PDF]

Hepat Oncol
Syed A, Akce M, Malla M.
europepmc   +1 more source

Durch anomere Amide ermöglichte divergente Synthese unsymmetrischer Harnstoffe, Carbamate, Thioester und Amide aus Aldehyden

Angewandte Chemie, Volume 138, Issue 37, 7 September 2026.
Eine divergente Aldehyd‐Funktionalisierungssequenz, ermöglicht durch ein anomeres Amid, erlaubt den Ein‐Topf‐Zugang zu unsymmetrischen Harnstoffen, Carbamaten, Thiocarbamaten, Thioestern und Amiden. Entscheidend für diese Transformation ist die Bildung von N‐Boc‐Hydroxamat‐Intermediaten, die als Plattformen für eine orthogonale Aktivierung über Lossen ...
Jasper L. Tyler, Meiyi Zeng, Julius Wiener, Marie‐Christin Leusmann, Colin Stein, Constantin G. Daniliuc, Frank Glorius   +6 more
wiley   +1 more source

Cost-effectiveness of finotonlimab plus bevacizumab versus sorafenib as first-line therapy in unresectable hepatocellular carcinoma in China. [PDF]

Hum Vaccin Immunother
Xu H, Yu S, Yang Y, Bian H, Wu Z, Xuan F.   +5 more
europepmc   +1 more source

Anomeric Amide Enabled Divergent Synthesis of Unsymmetrical Ureas, Carbamates, Thioesters, and Amides From Aldehydes

Angewandte Chemie International Edition, Volume 65, Issue 37, 7 September 2026.
An anomeric amide‐enabled divergent aldehyde functionalization sequence provides one‐pot access to unsymmetrical ureas, carbamates, thiocarbamates, thioesters, and amides. Key to this transformation is the formation of N‐Boc‐hydroxamate intermediates, which serve as platforms for orthogonal activation via Lossen‐type rearrangements, single‐electron ...
Jasper L. Tyler, Meiyi Zeng, Julius Wiener, Marie‐Christin Leusmann, Colin Stein, Constantin G. Daniliuc, Frank Glorius   +6 more
wiley   +1 more source

Tivozanib versus Sorafenib as Subsequent-Line Therapy for Advanced Renal Cell Carcinoma: A Cost-Effectiveness Analysis from a US Healthcare Perspective. [PDF]

Risk Manag Healthc Policy
Zhang X, Liu R, Hu Y, Ye J, Yang M, Xu J, Yang H, Yang X, Xu Z, Dai H, Xu H.   +10 more
europepmc   +1 more source

Sorafenib analogues exhibit dual Colistin-potentiating and anti-MRSA activity. [PDF]

RSC Med Chem
Sorge A, Stiles A, Nemeth AM, O'Keefe I, Melander RJ, Doi Y, Ernst RK, Melander C.   +7 more
europepmc   +1 more source

Sorafenib Restores Pentose Phosphate Pathway-Related Redox Homeostasis via the c-Raf/HSP90/G6PD Axis in Hepatic Ischemia-Reperfusion Injury. [PDF]

MedComm (2020)
Gao F, Dong L, Tan Y, Zhang Z, Xu S, Lou Z, Wu Y, Chen S, Zhuang L, Lian Z, Zheng S, Qiu N, Wang K, Xu X.   +13 more
europepmc   +1 more source

Stress‑induced catecholamines attenuate sorafenib efficacy by inhibiting ferroptosis in β2‑adrenergic receptor positive renal cell carcinoma. [PDF]

Int J Oncol
Ushijima M, Naito S, Ito H, Narisawa T, Ichiyanagi O, Kanno H, Fukuhara H, Takai Y, Yagi M, Yamagishi A, Nishida H, Obara Y, Tsuchiya N.   +12 more
europepmc   +1 more source

Sorafenib, a clinical kinase inhibitor, attenuates <i>Streptococcus pneumoniae</i> pathogenesis and reduces disease progression <i>in vivo</i>. [PDF]

mBio
Abraham J, Sagilkumar AC, Dhyani H, Panchal CM, Aziz S, Priyadatha MK, Ruth A, Bhaskaran K, Chandrika SK, Shaima S, Varghese R, Neeravi A, Veeraragavan B, Narayanaswamy N, Ganesan S, Subramanian K.   +15 more
europepmc   +1 more source